Bluejay Diagnostics (BJDX) Enterprise Value (2020 - 2026)

Bluejay Diagnostics (BJDX) has 7 years of Enterprise Value data on file, last reported at -$3.7 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 18.24% year-over-year to -$3.7 million; the trailing twelve-month figure through Mar 2026 stood at -$3.7 million (down 18.24% YoY), and the FY2025 full-year result was -$5.2 million, down 20.06% from the prior year.
• Enterprise Value grew to -$3.7 million in Q1 2026, from -$5.2 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$2.2 million in Q4 2023 to a low of -$17.1 million in Q1 2022.
• A 5-year average of -$6.8 million and a median of -$5.1 million in 2023 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value plunged 470.33% in 2022 and surged 78.17% in 2023, its largest moves.
• Tracing BJDX's Enterprise Value over 5 years: stood at -$10.1 million in 2022, then surged by 78.17% to -$2.2 million in 2023, then slumped by 94.79% to -$4.3 million in 2024, then declined by 20.06% to -$5.2 million in 2025, then gained by 28.66% to -$3.7 million in 2026.
• Business Quant data shows BJDX's Enterprise Value at -$3.7 million in Q1 2026, -$5.2 million in Q4 2025, and -$3.1 million in Q3 2025.